1881275-65-5 Usage
Uses
Used in Pharmaceutical Industry:
(R)-4-Cbz-2-(aMinoMethyl)Morpholine is used as a key intermediate for the synthesis of various pharmaceuticals. Its protective Cbz group and chiral center allow for the creation of a wide range of drug candidates with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, (R)-4-Cbz-2-(aMinoMethyl)Morpholine serves as a vital component in the development of new agrochemicals. Its unique properties facilitate the synthesis of compounds with potential applications in pest control, crop protection, and other agricultural areas.
Used in Organic Chemistry:
As a versatile intermediate in organic chemistry, (R)-4-Cbz-2-(aMinoMethyl)Morpholine is employed in the synthesis of various organic compounds. Its protective Cbz group and chiral center enable the development of a diverse array of chemical products with different applications in research and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 1881275-65-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,8,8,1,2,7 and 5 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1881275-65:
(9*1)+(8*8)+(7*8)+(6*1)+(5*2)+(4*7)+(3*5)+(2*6)+(1*5)=205
205 % 10 = 5
So 1881275-65-5 is a valid CAS Registry Number.
1881275-65-5Relevant academic research and scientific papers
Disubstituted pyrimidines as Lck inhibitors
Hunt, Julianne A.,Beresis, Richard T.,Goulet, Joung L.,Holmes, Mark A.,Hong, Xinfang J.,Kovacs, Ernest,Mills, Sander G.,Ruzek, Rowena D.,Wong, Frederick,Hermes, Jeffrey D.,Park, Young-Whan,Salowe, Scott P.,Sonatore, Lisa M.,Wu, Lin,Woods, Andrea,Zaller, Dennis M.,Sinclair, Peter J.
supporting information; experimental part, p. 5440 - 5443 (2010/04/26)
We have developed a family of 4-benzimidazolyl-N-piperazinethyl-pyrimidin-2-amines that are subnanomolar inhibitors of Lck. A subset of these Lck inhibitors, with heterocyclic substituents at the benzimidazole C5, are also low-nanomolar inhibitors of cell
SRC kinase inhibitor compounds
-
, (2008/06/13)
Pyrimidine compounds (Formula I), or their pharmaceutically acceptable salts, hydrates, solvates, crystal forms and individual diastereomers, and pharmaceutical compositions including the same, which are inhibitors of tyrosine kinase enzymes, and as such are useful in the prophylaxis and treatment of protein tyrosine kinase-associated disorders, such as immune diseases, hyperproliferative disorders and other diseases in which inappropriate protein kinase action is believed to play a role, such as cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis and psoriasis.
